loader image
BUY TOKENS
BUY TOKENS

INTERVIEW WITH CHIEF PUBLIC RELATIONS OFFICER

Why do we see a peach in your project logo?

Since ancient times, the Peach has been a symbol of youth and immortality. The peach fruit symbolizes the continuous process of life renewal. 10 years ago, one of our founders decided to make a peach part of our logo

What are the priority areas of your project?

The main area of our project is the development of Global Longevity Labs. The laboratory’s mission is to restore cellular health and resilience through cellular rejuvenation to reverse diseases, injuries and disorders that can occur throughout life.

How do you help develop other projects that deal with longevity issues?

Since 2015, Global Longevity Metaverse has been actively involved in the development of many projects – here are some of them:

– Young Scientists from South America are exploring Mitophagy, which reduces activation of the cytosolic mtDNA-dependent Inflammatory response cGAS/STING during aging

– In Central America we are helping a startup to study Pleiotropy and factors of interaction with diseases

– Immunological aspects of central neurodegeneration are being studied in Spain with our financial support

– We help specialists from France to study problems in the field of Aging and Cancer

– Computer modeling of gene networks associated with aging is successfully studied in Belgium with our help

– Portuguese scientists are studying cyclic overexpression of Yamanaka factors in vivo with our financial support

– Together with other investors, we are participating in the financing of an American project to develop human organs using embryo models and chimeras

– Recently started funding a very promising study on Rejuvenation of aged stem cells (therapeutic strategies for prolonging health and lifespan)

– Together with our Chinese partners, we are actively funding research on Small Extracellular Vesicles from Young Plasma, which reverse age-related functional impairment by improving mitochondrial energy metabolism.

– Previously, we also took part in the organization of the Global Longevity Institute and the Liver Longevity Project, which are successfully developing in Eastern Europe.
It is very important to separately explain that all projects that we finance and help develop are absolutely independent and autonomous organizations. Global Longevity Metaverse in this case acts as a classic decentralized network blockchain ecosystem, which allows all participants to achieve their goals and objectives in a decentralized network. This is the basis for the safe and reliable operation of Global Longevity Metaverse by the blockchain type.

Who and how provides funding?

Our project is fully funded by Global Longevity Science Foundation. It is possible that in the future we will consider funding from other sources. But now the financial capabilities of the Foundation are sufficient for the full-fledged work of the Global Longevity Metaverse

Who are the founders of Global Longevity Metaverse?

Both of our founders are successful businessmen in the field of international energy trade, engaged in stock trading and development activities. But most importantly, they have long been financing the development of scientific projects and research on longevity.

MAKE A STEP TOWADS TO

LONGEVITY!

START YOUR JOURNEY TO GLOBAL LONGEVITY
GET IN TOUCH WITH US

     

    Global Longevity Disclaimer

    Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

    Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

    Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

    Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

    Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

    The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

    This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

    The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

    The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

    This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

    Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.

    I agree What is Disclaimer?